Towards Understanding the Pathogenesis of Rheumatic Fever

Scandinavian Journal of Rheumatology

Volumn 25, Issue 3, 1996, Pages 127-131

  Carapetis, J R ^b   Currie, B J ^b   Good, M F ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NONE

Author keywords

Pathogenesis; Rheumatic fever

Indexed keywords

STREPTOCOCCUS VACCINE;

HUMAN; IMMUNE RESPONSE; MEDICAL RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; VACCINATION;

HUMANS; RHEUMATIC FEVER; STREPTOCOCCUS PYOGENES;

EID: 0029890709     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609080000     Document Type: Review

References (49)

1. Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory. Med J Aust 1996; 164: 146-9.
2. Markowitz M. Changing epidemiology of group A streptococcal infections. Pediatr Infect Dis J 1994; 13: 557-60.
3. Stevens DL. Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J 1994; 13: 561-6.
4. McCarty M. Theories of pathogenesis of streptococcal complications. In: Wannamaker LW, Matsen JM, eds. Streptococci and streptococcal diseases. New York. Academic Press 1972; 517-26.
5. McCarty M. The role of immunological mechanisms in the pathogenesis of rheumatic fever. In: Read SE, Zabriskie JB, eds. Streptococcal diseases and the immune response. New York, Academic Press 1980; 13-21.
6. Taranta A, Torosdag S, Metrakos JD, Jegier W, Uchida I. Rheumatic fever in monozygotic and dizygotic twins (abstract). Circulation 1959; 20: 778.
7. Hafez M, Chakravarti A, El-Shennawy F, El-Morsi Z, El-Sallab SH, Al-Tonbary Y. HLA antigens and acute rheumatic fever: evidence for a recessive susceptibility gene linked to HLA. Genet Epidemiol 1985; 2: 273-82.
8. Khanna AK, Buskirk DR, Williams RCJr, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 1989; 83: 1710-6.
9. Feldman BM, Zabriskie JB, Silverman ED, Laxer RM. Diagnostic use of B-cell alloantigen D8/17 in rheumatic chorea. J Pediatr 1993; 123: 84-6.
10. Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991; 83: 1995-8.
11. Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986; 77: 2019-26.
12. Jhinghan B, Mehra NK, Reddy KS, Taneja V, Vaidya MC, Bhatiu ML. HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens 1986; 27: 172-8.
13. Patarroyo ME, Winchester RJ, Vejerano A, et al. Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 1979; 278: 173-4.
14. Rammelkamp CH, Wannamaker LW, Denny FW. The epidemiology and prevention of rheumatic fever. Bull N Y Acad Med 1952; 28: 321-34.
15. Spagnuolo M, Pasternack B, Taranta A. Risk of rheumatic fever recurrences after streptococcal infections: prospective study of clinical and social factors. N Engl J Med 1971; 285: 641-7.
16. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population I: Factors related to the attack rate of rheumatic fever. N Engl J Med 1961; 265: 559-66.
17. Kaplan EL. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Circulation 1993; 88: 1964-72.
18. Kuttner AG, Krumweide E. Observations on the effect of streptococcal upper respiratory infections in rheumatic children: a three-year study. J Clin Invest 1941; 20: 273-87.
19. Stollerman GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 1991; 61: 131-42.
20. Ayoub EM, Kaplan EL. Host-parasite interaction in the pathogenesis of rheumatic fever. J Rheumatol 1991; 18 (Suppl 30): 6-13.
21. Eichbaum QG, Beatty DW, Parker MI. Identification of cardiac autoantigens in human heart DNA libraries using acute rheumatic fever sera. J Autoimmun 1994; 7: 243-61.
22. Bessen D, Jones KF, Fischetti VA. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 1989; 169: 269-283.
23. Martin DR, Voss LM, Walker SJ, Lennon D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J 1994; 13: 264-9.
24. Martin DR, Single LA. Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 1993; 167: 1112-7.
25. Bessen DE, Hollingshead SK. Allelic polymorphism of emm loci provides evidence for horizontal gene spread in group A streptococci. Proc Natl Acad Sci USA 1994; 91: 3280-4.
26. Carapetis J, Gardiner D, Currie B, Mathews JD. Multiple strains of Streptococcus pyagenes in skin sores of Aboriginal Australians. J Clin Microbiol 1995; 33: 1471-2.
27. Tran P-OT, Johnson DR, Kaplan EL. The presence of M protein in nontypeable group A streptococcal upper respiratory tract isolates from Southeast Asia. J Infect Dis 1994; 169: 658-61.
28. Zabriskie JB. Rheumatic fever: a model for the pathological consequences of microbial-host mimicry. Clin Exp Rheumatol 1986; 4: 65-73.
29. Taranta A, Markowitz M. Rheumatic fever. Dordrecht; Kluwer Academic Publishers, 1989.
30. Kaplan MH. Rheumatic fever, rheumatic heart disease, and the streptococcal connection: the role of streptococcal antigens cross-reactive with heart tissue. Rev Infect Dis 1979; 1: 988-96.
31. Raizada V, Williams RCJr, Chopra P, et al. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med 1983; 74: 90-6.
32. Husby G, Arora R, Williams RC Jr, Khaw BA, Harber E, Butler C. Immunofluorescence studies of florid rheumatic Aschoff lesions. Arthritis Rheum 1986; 29: 207-11.
33. Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 1989; 52: 225-37.
34. Samsonov MY, Tilz GP, Pisklakov VP, et al. Serum-soluble receptors for tumor necrosis factor-α and interleukin-2, and neopterin in acute rheumatic fever. Clin Immunol Immunopathol 1995; 74: 31-4.
35. Kumar V, Ganguly NK, Anand IS, Wahi PL. Release of oxygen free radicals by macrophages and neutrophils in patients with rheumatic fever. Eur Heart J 1991; 12 (Suppl D): 163-5.
36. Morris K, Mohan C, Wahi PL, Anand IS, Ganguly NK. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study. Clin Exp Immunol 1993; 91: 429-36.
37. Alarcon-Riquelme ME, Alarcon-Segovia D, Loredo-Abdala A, Alcocer-Varela J. T lymphocyte subsets, suppressor and contrasuppressor cell functions and production of interleukin-2 in the peripheral blood of rheumatic fever patients and their apparently healthy siblings. Clin Immunol Immunopathol 1990; 55: 120-8.
38. Read SE, Fischetti VA, Utermohlen V, Falk RE, Zabriskie JB. Cellular reactivity studies to streptococcal antigens. J Clin Invest 1974; 54: 439-50.
39. Pruksakorn S, Currie B, Brandt E, et al. Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol 1994; 6: 1235-44.
40. Cromartie WJ, Craddock JG. Rheumatic-like cardiac lesions in mice. Science 1966; 154: 285-7.
41. Dos Reis GA, Gaspar MI, Barcinski MA. Immune recognition in the streptococcal carditis of mice: the role of macrophages in the generation of heart-reactive lymphocytes. J Immunol 1982; 128: 1514-21.
42. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993; 167: 997-1002.
43. Schmidt K-H, Gerlach D. Wollweber L, et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF. Infect Immun 1995; 63: 4569-75.
44. Kotb M. Infection and autoimmunity: a story of the host, the pathogen, and the copathogen. Clin Immunol Immunopathol 1995; 74: 10-22.
45. Dale JB, Chiang EY, Lederer JW. Recombinant tetravalent group A streptotoccal M protein vaccine. J Immunol 1993; 151: 2188-2194.
46. Pruksakorn S, Currie B, Brandt E, et al. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 1994; 344: 639-42.
47. Bessen D, Fischetti VA. Synthetic peptide vaccine against mucosal colonization by group A streptococci: protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990; 145: 1251-6.
48. Bronze MS, Courtney HS, Dale JB. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J Immunol 1992; 148: 888-93.
49. Van Buynder PG, Gaggin JA, Martin D, Pugsley D, Mathews JD. Streptococcal infection and renal disease markers in Australian Aboriginal children. Med J Aust 1992; 156: 537-40.